vs
Side-by-side financial comparison of Bilibili Inc. (BILI) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $1.3B, roughly 1.2× Bilibili Inc.). Bilibili Inc. runs the higher net margin — 6.0% vs 4.4%, a 1.5% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 26.2%). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 27.3%).
Bilibili, nicknamed B Site, is a Chinese online video sharing website based in Shanghai where users can submit, view, and add overlaid commentary on videos.
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
BILI vs ONC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.5B |
| Net Profit | $75.7M | $66.5M |
| Gross Margin | 37.0% | 90.5% |
| Operating Margin | 5.8% | 12.4% |
| Net Margin | 6.0% | 4.4% |
| Revenue YoY | 26.2% | 32.8% |
| Net Profit YoY | 143.0% | 143.8% |
| EPS (diluted) | $1.14 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.3B | $1.5B | ||
| Q3 25 | $1.1B | $1.4B | ||
| Q2 25 | $1.0B | $1.3B | ||
| Q1 25 | $965.1M | $1.1B | ||
| Q4 24 | $1.0B | $1.1B | ||
| Q3 24 | $1.0B | $1.0B | ||
| Q2 24 | $843.1M | $929.2M | ||
| Q1 24 | $784.5M | $751.7M |
| Q4 25 | $75.7M | $66.5M | ||
| Q3 25 | $65.9M | $124.8M | ||
| Q2 25 | $30.5M | $94.3M | ||
| Q1 25 | $-1.5M | $1.3M | ||
| Q4 24 | $-176.0M | $-151.9M | ||
| Q3 24 | $11.4M | $-121.3M | ||
| Q2 24 | $83.7M | $-120.4M | ||
| Q1 24 | $-105.9M | $-251.2M |
| Q4 25 | 37.0% | 90.5% | ||
| Q3 25 | 36.7% | 86.1% | ||
| Q2 25 | 36.5% | 87.5% | ||
| Q1 25 | 36.3% | 85.2% | ||
| Q4 24 | 36.2% | 85.8% | ||
| Q3 24 | 34.9% | 83.0% | ||
| Q2 24 | 29.9% | 85.1% | ||
| Q1 24 | 28.3% | 83.4% |
| Q4 25 | 5.8% | 12.4% | ||
| Q3 25 | 4.6% | 11.5% | ||
| Q2 25 | 3.4% | 6.7% | ||
| Q1 25 | 0.2% | 1.0% | ||
| Q4 24 | -16.0% | -7.0% | ||
| Q3 24 | 0.9% | -12.0% | ||
| Q2 24 | 9.5% | -11.5% | ||
| Q1 24 | -14.5% | -34.8% |
| Q4 25 | 6.0% | 4.4% | ||
| Q3 25 | 6.1% | 8.8% | ||
| Q2 25 | 3.0% | 7.2% | ||
| Q1 25 | -0.2% | 0.1% | ||
| Q4 24 | -17.5% | -13.5% | ||
| Q3 24 | 1.1% | -12.1% | ||
| Q2 24 | 9.9% | -13.0% | ||
| Q1 24 | -13.5% | -33.4% |
| Q4 25 | $1.14 | $0.05 | ||
| Q3 25 | $1.05 | $0.08 | ||
| Q2 25 | $0.51 | $0.06 | ||
| Q1 25 | $0.00 | $0.00 | ||
| Q4 24 | $0.21 | $-0.10 | ||
| Q3 24 | $-0.03 | $-0.09 | ||
| Q2 24 | $-0.20 | $-0.09 | ||
| Q1 24 | $-1.80 | $-0.19 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $2.7B | $4.5B |
| Total DebtLower is stronger | $1.4B | $836.4M |
| Stockholders' EquityBook value | $2.2B | $4.4B |
| Total Assets | $5.9B | $8.2B |
| Debt / EquityLower = less leverage | 0.62× | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.7B | $4.5B | ||
| Q3 25 | $2.4B | $4.0B | ||
| Q2 25 | — | $2.8B | ||
| Q1 25 | $1.9B | $2.5B | ||
| Q4 24 | $1.8B | $2.6B | ||
| Q3 24 | $11.7B | $2.7B | ||
| Q2 24 | — | $2.6B | ||
| Q1 24 | $1.1B | $2.8B |
| Q4 25 | $1.4B | $836.4M | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $700.3M | — | ||
| Q4 24 | $662.5M | — | ||
| Q3 24 | $4.3B | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $684.5M | — |
| Q4 25 | $2.2B | $4.4B | ||
| Q3 25 | $2.1B | $4.1B | ||
| Q2 25 | — | $3.8B | ||
| Q1 25 | $2.0B | $3.5B | ||
| Q4 24 | $1.9B | $3.3B | ||
| Q3 24 | $13.7B | $3.4B | ||
| Q2 24 | — | $3.4B | ||
| Q1 24 | $1.9B | $3.4B |
| Q4 25 | $5.9B | $8.2B | ||
| Q3 25 | $5.6B | $7.6B | ||
| Q2 25 | — | $6.3B | ||
| Q1 25 | $4.6B | $5.8B | ||
| Q4 24 | $4.5B | $5.9B | ||
| Q3 24 | $32.0B | $5.8B | ||
| Q2 24 | — | $5.7B | ||
| Q1 24 | $4.2B | $5.7B |
| Q4 25 | 0.62× | 0.19× | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.35× | — | ||
| Q4 24 | 0.34× | — | ||
| Q3 24 | 0.31× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.36× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $263.1M | $417.3M |
| Free Cash FlowOCF − Capex | — | $379.8M |
| FCF MarginFCF / Revenue | — | 25.4% |
| Capex IntensityCapex / Revenue | — | 2.5% |
| Cash ConversionOCF / Net Profit | 3.47× | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | — | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $263.1M | $417.3M | ||
| Q3 25 | $283.2M | $402.6M | ||
| Q2 25 | $277.7M | $263.6M | ||
| Q1 25 | $179.4M | $44.1M | ||
| Q4 24 | $191.9M | $75.2M | ||
| Q3 24 | $2.2B | $188.4M | ||
| Q2 24 | — | $-95.6M | ||
| Q1 24 | $88.3M | $-308.6M |
| Q4 25 | — | $379.8M | ||
| Q3 25 | — | $354.5M | ||
| Q2 25 | — | $219.8M | ||
| Q1 25 | $174.5M | $-12.3M | ||
| Q4 24 | — | $-17.3M | ||
| Q3 24 | — | $54.7M | ||
| Q2 24 | — | $-205.5M | ||
| Q1 24 | — | $-465.1M |
| Q4 25 | — | 25.4% | ||
| Q3 25 | — | 25.1% | ||
| Q2 25 | — | 16.7% | ||
| Q1 25 | 18.1% | -1.1% | ||
| Q4 24 | — | -1.5% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | -22.1% | ||
| Q1 24 | — | -61.9% |
| Q4 25 | — | 2.5% | ||
| Q3 25 | — | 3.4% | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | 0.5% | 5.0% | ||
| Q4 24 | — | 8.2% | ||
| Q3 24 | — | 13.3% | ||
| Q2 24 | — | 11.8% | ||
| Q1 24 | — | 20.8% |
| Q4 25 | 3.47× | 6.28× | ||
| Q3 25 | 4.30× | 3.22× | ||
| Q2 25 | 9.11× | 2.79× | ||
| Q1 25 | — | 34.71× | ||
| Q4 24 | — | — | ||
| Q3 24 | 195.23× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BILI
| Value-added services (VAS) | $466.4M | 37% |
| Advertising | $435.0M | 34% |
| Mobile games | $220.3M | 17% |
| Other | $80.8M | 6% |
| IP derivatives and others | $68.2M | 5% |
ONC
Segment breakdown not available.
